These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8412984)

  • 21. Defects in the processing of procollagen to collagen are demonstrable in cultured fibroblasts from patients with the Ehlers-Danlos and osteogenesis imperfecta syndromes.
    Minor RR; Sippola-Thiele M; McKeon J; Berger J; Prockop DJ
    J Biol Chem; 1986 Jul; 261(21):10006-14. PubMed ID: 3733683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Morphofunctional aspects of genetic analysis of osteogenesis imperfecta in cultured skin fibroblasts].
    Meerson EM; Barer FS; Berezhnyĭ AP; Prokhorova EV; Maliavko TP; Chernysheva EV; Neustroeva EP
    Biull Eksp Biol Med; 1992 Jul; 114(7):86-8. PubMed ID: 1421323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen.
    Wenstrup RJ; Hunter AG; Byers PH
    Hum Genet; 1986 Sep; 74(1):47-53. PubMed ID: 3759085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Mascara T; Chan D; Cole WG
    Biochem J; 1984 Jan; 217(1):103-15. PubMed ID: 6421277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The substitution of arginine for glycine 85 of the alpha 1(I) procollagen chain results in mild osteogenesis imperfecta. The mutation provides direct evidence for three discrete domains of cooperative melting of intact type I collagen.
    Deak SB; Scholz PM; Amenta PS; Constantinou CD; Levi-Minzi SA; Gonzalez-Lavin L; Mackenzie JW
    J Biol Chem; 1991 Nov; 266(32):21827-32. PubMed ID: 1718984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta.
    Byers PH; Shapiro JR; Rowe DW; David KE; Holbrook KA
    J Clin Invest; 1983 Mar; 71(3):689-97. PubMed ID: 6826730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts.
    Milewicz DM; Pyeritz RE; Crawford ES; Byers PH
    J Clin Invest; 1992 Jan; 89(1):79-86. PubMed ID: 1729284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta.
    Galicka A; Wolczyñski S; Anchim T; Surazyñski A; Lesniewicz R; Palka J
    Eur J Biochem; 2001 Apr; 268(7):2172-8. PubMed ID: 11277941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secreted collagen ratios in normal human and osteogenesis imperfecta skin fibroblasts.
    Fraser J; Lancaster GA; Scriver CR
    Connect Tissue Res; 1983; 11(1):57-67. PubMed ID: 6221880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases.
    Pace JM; Chitayat D; Atkinson M; Wilcox WR; Schwarze U; Byers PH
    J Med Genet; 2002 Jan; 39(1):23-9. PubMed ID: 11826020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients.
    Mörike M; Brenner RE; Bushart GB; Teller WM; Vetter U
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):73-7. PubMed ID: 1520286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of mutant alpha (I)-procollagen in osteoblast and fibroblast cultures from a proband with osteogenesis imperfecta type IV.
    Chipman SD; Shapiro JR; McKinstry MB; Stover ML; Branson P; Rowe DW
    J Bone Miner Res; 1992 Jul; 7(7):793-805. PubMed ID: 1642148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The phenotypic features of osteogenesis imperfecta resulting from a mutation of the carboxyl-terminal pro alpha 1 (I) propeptide that impairs the assembly of type I procollagen and formation of the extracellular matrix.
    Cole WG; Chow CW; Bateman JF; Sillence DO
    J Med Genet; 1996 Nov; 33(11):965-7. PubMed ID: 8950680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mouse 3T6 fibroblast cell culture model for the study of normal and protein-engineered collagen synthesis and deposition into the extracellular matrix.
    Lamandé SR; Bateman JF
    Matrix; 1993 Jul; 13(4):323-30. PubMed ID: 8412990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lethal osteogenesis imperfecta: abnormal collagen metabolism and biochemical characteristics of hypophosphatasia.
    Royce PM; Blumberg A; Zurbrügg RP; Zimmermann A; Colombo JP; Steinmann B
    Eur J Pediatr; 1988 Aug; 147(6):626-31. PubMed ID: 3181205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteogenesis Imperfecta model.
    Kuznetsova NV; Forlino A; Cabral WA; Marini JC; Leikin S
    Matrix Biol; 2004 May; 23(2):101-12. PubMed ID: 15246109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II.
    Bonadio J; Byers PH
    Nature; 1985 Jul 25-31; 316(6026):363-6. PubMed ID: 4022126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective Proteolytic Processing of Fibrillar Procollagens and Prodecorin Due to Biallelic BMP1 Mutations Results in a Severe, Progressive Form of Osteogenesis Imperfecta.
    Syx D; Guillemyn B; Symoens S; Sousa AB; Medeira A; Whiteford M; Hermanns-Lê T; Coucke PJ; De Paepe A; Malfait F
    J Bone Miner Res; 2015 Aug; 30(8):1445-56. PubMed ID: 25656619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta.
    Raghunath M; Bruckner P; Steinmann B
    J Mol Biol; 1994 Feb; 236(3):940-9. PubMed ID: 8114103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An in vitro model to evaluate the properties of matrices produced by fibroblasts from osteogenesis imperfecta and Ehlers-Danlos Syndrome patients.
    Micha D; Pals G; Smit TH; Ghazanfari S
    Biochem Biophys Res Commun; 2020 Jan; 521(2):310-317. PubMed ID: 31668813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.